Template:Hepatitis B post exposure prophylaxis: Difference between revisions
Ostermayer (talk | contribs) (Created page with "''Treatment is generally initiated after coordination with occupational health and infectious disease service and based the the exposed patient's vaccination history''<ref> Po...") |
(Administration of HBIG update) |
||
| (3 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
===[[Hepatitis B]] Post-Exposure Prophylaxis=== | |||
''Treatment is generally initiated after coordination with occupational health and infectious disease service and based the the exposed patient's vaccination history''<ref> Postexposure prophylaxis to prevent hepatitis b virus infection. CDC MMWR http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5516a3.htm?s_cid=rr5516a3_e</ref> | ''Treatment is generally initiated after coordination with occupational health and infectious disease service and based the the exposed patient's vaccination history''<ref> Postexposure prophylaxis to prevent hepatitis b virus infection. CDC MMWR http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5516a3.htm?s_cid=rr5516a3_e</ref> | ||
===Unvaccinated=== | |||
====Unvaccinated==== | |||
*If the source is HBsAg(+) then give HBIG x1 and initiate HBV vaccine in two separate sites | *If the source is HBsAg(+) then give HBIG x1 and initiate HBV vaccine in two separate sites | ||
*If source is HGsAG(-) then start the HBV vaccine series | *If source is HGsAG(-) then start the HBV vaccine series | ||
*If source blood is unavailable and high risk then give HBIG x1 initiate the HBV series | *If source blood is unavailable and high risk then give HBIG x1 initiate the HBV series | ||
**If source blood is low risk and unavailable then begin HBV series | **If source blood is low risk and unavailable then begin HBV series | ||
===Previously vaccinated non responder (one series)=== | |||
====Previously vaccinated non responder (one series)==== | |||
''Non responder status is defined as anti-has <10mIU/mL'' | ''Non responder status is defined as anti-has <10mIU/mL'' | ||
*If the source is HBsAg(+) then give HBIG x 1 and begin revaccination series | *If the source is HBsAg(+) then give HBIG x 1 and begin revaccination series | ||
| Line 11: | Line 14: | ||
*If source is HBsAg(-) then no treatment is needed | *If source is HBsAg(-) then no treatment is needed | ||
*If source blood is unavailable and high risk then treat as if HBsAg(+) | *If source blood is unavailable and high risk then treat as if HBsAg(+) | ||
===Previously vaccinated non responder (two series)=== | |||
====Previously vaccinated non responder (two series)==== | |||
''Non responder status is defined as anti-has <10mIU/mL'' | ''Non responder status is defined as anti-has <10mIU/mL'' | ||
*If the source is HBsAg(+) then give HBIG x2 and no HBV series | *If the source is HBsAg(+) then give HBIG x2 and no HBV series | ||
*If source is HGsAG(-) then no treatment is needed | *If source is HGsAG(-) then no treatment is needed | ||
*If source blood is unavailable then initiate the HBV series | *If source blood is unavailable then initiate the HBV series | ||
===Treatment Dosing=== | |||
'' | ====Treatment Dosing==== | ||
''No contraindications for pregnancy or breast feeding'' | |||
*HBIG 0.06 mL/kg IM | *HBIG 0.06 mL/kg IM | ||
**Give in opposite arm from hepatitis B vaccine if patient also receiving vaccine | |||
*Vaccination series: HBV vaccine options: | *Vaccination series: HBV vaccine options: | ||
**Engerix-B 20mcg IM | **Engerix-B 20mcg IM | ||
**Recombivax HB 10mcg IM | **Recombivax HB 10mcg IM | ||
Latest revision as of 21:58, 24 January 2020
Hepatitis B Post-Exposure Prophylaxis
Treatment is generally initiated after coordination with occupational health and infectious disease service and based the the exposed patient's vaccination history[1]
Unvaccinated
- If the source is HBsAg(+) then give HBIG x1 and initiate HBV vaccine in two separate sites
- If source is HGsAG(-) then start the HBV vaccine series
- If source blood is unavailable and high risk then give HBIG x1 initiate the HBV series
- If source blood is low risk and unavailable then begin HBV series
Previously vaccinated non responder (one series)
Non responder status is defined as anti-has <10mIU/mL
- If the source is HBsAg(+) then give HBIG x 1 and begin revaccination series
- Can also opt to perform second HBIG administration in one month
- If source is HBsAg(-) then no treatment is needed
- If source blood is unavailable and high risk then treat as if HBsAg(+)
Previously vaccinated non responder (two series)
Non responder status is defined as anti-has <10mIU/mL
- If the source is HBsAg(+) then give HBIG x2 and no HBV series
- If source is HGsAG(-) then no treatment is needed
- If source blood is unavailable then initiate the HBV series
Treatment Dosing
No contraindications for pregnancy or breast feeding
- HBIG 0.06 mL/kg IM
- Give in opposite arm from hepatitis B vaccine if patient also receiving vaccine
- Vaccination series: HBV vaccine options:
- Engerix-B 20mcg IM
- Recombivax HB 10mcg IM
- ↑ Postexposure prophylaxis to prevent hepatitis b virus infection. CDC MMWR http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5516a3.htm?s_cid=rr5516a3_e
